Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1580327rdf:typepubmed:Citationlld:pubmed
pubmed-article:1580327lifeskim:mentionsumls-concept:C0681853lld:lifeskim
pubmed-article:1580327lifeskim:mentionsumls-concept:C0015350lld:lifeskim
pubmed-article:1580327lifeskim:mentionsumls-concept:C0178664lld:lifeskim
pubmed-article:1580327lifeskim:mentionsumls-concept:C0867389lld:lifeskim
pubmed-article:1580327lifeskim:mentionsumls-concept:C1527148lld:lifeskim
pubmed-article:1580327lifeskim:mentionsumls-concept:C0591833lld:lifeskim
pubmed-article:1580327pubmed:issue5lld:pubmed
pubmed-article:1580327pubmed:dateCreated1992-6-11lld:pubmed
pubmed-article:1580327pubmed:abstractTextThe development of glomerulosclerosis was studied in murine chronic graft-versus-host disease (GvHD), which is a model for human systemic lupus erythematosus. The authors investigated the distribution patterns of six components of the extracellular matrix (ECM), i.e., laminin, fibronectin, collagen types I, III, IV, and VI during the course of the disease. All of these ECM components except collagen type I were found in the glomeruli of normal mice, where all of them were intrinsic constituents of the mesangium. Laminin, fibronectin, and collagen type IV were also found in the glomerular capillary walls. Starting 6 weeks after the induction of GvHD and continuing at week 8, the onset of an expansion of the mesangial matrix was observed. At the same time, the amounts of laminin, fibronectin, and collagen types IV and VI increased. Ten weeks after the onset of the disease, glomerulosclerosis developed. Traces of the interstitial collagen type I were found in sclerotic glomeruli. The levels of four ECM components, i.e., collagens III, IV, VI, and laminin were markedly decreased in the sclerotic glomeruli as compared with week 8. In contrast, the amount of fibronectin in the sclerotic glomeruli increased dramatically. Immunoelectron microscopic examination showed fibronectin in the sclerotic lesions, in contrast to laminin, collagen type I, and collagen type IV. It is concluded that the sclerotic lesions in murine chronic GvHD contain fibronectin. The small amounts of the ECM components laminin, as well as collagens III, IV, and VI in the sclerotic glomeruli in GvHD, might represent remnants of mesangial material and collapsed capillary walls. These components are probably replaced by increased production and/or accumulation of collagen type I and fibronectin.lld:pubmed
pubmed-article:1580327pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1580327pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1580327pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1580327pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1580327pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1580327pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1580327pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1580327pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1580327pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1580327pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1580327pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1580327pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1580327pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1580327pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1580327pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1580327pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1580327pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1580327pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1580327pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1580327pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1580327pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1580327pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1580327pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1580327pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1580327pubmed:languageenglld:pubmed
pubmed-article:1580327pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1580327pubmed:citationSubsetAIMlld:pubmed
pubmed-article:1580327pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1580327pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1580327pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1580327pubmed:statusMEDLINElld:pubmed
pubmed-article:1580327pubmed:monthMaylld:pubmed
pubmed-article:1580327pubmed:issn0002-9440lld:pubmed
pubmed-article:1580327pubmed:authorpubmed-author:PrinsFFlld:pubmed
pubmed-article:1580327pubmed:authorpubmed-author:FoidartJ MJMlld:pubmed
pubmed-article:1580327pubmed:authorpubmed-author:HoedemaekerP...lld:pubmed
pubmed-article:1580327pubmed:authorpubmed-author:MunautCClld:pubmed
pubmed-article:1580327pubmed:authorpubmed-author:BruijnJ AJAlld:pubmed
pubmed-article:1580327pubmed:authorpubmed-author:BergijkE CEClld:pubmed
pubmed-article:1580327pubmed:authorpubmed-author:BaeldeJ JJJlld:pubmed
pubmed-article:1580327pubmed:issnTypePrintlld:pubmed
pubmed-article:1580327pubmed:volume140lld:pubmed
pubmed-article:1580327pubmed:ownerNLMlld:pubmed
pubmed-article:1580327pubmed:authorsCompleteYlld:pubmed
pubmed-article:1580327pubmed:pagination1147-56lld:pubmed
pubmed-article:1580327pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:1580327pubmed:meshHeadingpubmed-meshheading:1580327-...lld:pubmed
pubmed-article:1580327pubmed:meshHeadingpubmed-meshheading:1580327-...lld:pubmed
pubmed-article:1580327pubmed:meshHeadingpubmed-meshheading:1580327-...lld:pubmed
pubmed-article:1580327pubmed:meshHeadingpubmed-meshheading:1580327-...lld:pubmed
pubmed-article:1580327pubmed:meshHeadingpubmed-meshheading:1580327-...lld:pubmed
pubmed-article:1580327pubmed:meshHeadingpubmed-meshheading:1580327-...lld:pubmed
pubmed-article:1580327pubmed:meshHeadingpubmed-meshheading:1580327-...lld:pubmed
pubmed-article:1580327pubmed:meshHeadingpubmed-meshheading:1580327-...lld:pubmed
pubmed-article:1580327pubmed:meshHeadingpubmed-meshheading:1580327-...lld:pubmed
pubmed-article:1580327pubmed:meshHeadingpubmed-meshheading:1580327-...lld:pubmed
pubmed-article:1580327pubmed:meshHeadingpubmed-meshheading:1580327-...lld:pubmed
pubmed-article:1580327pubmed:meshHeadingpubmed-meshheading:1580327-...lld:pubmed
pubmed-article:1580327pubmed:meshHeadingpubmed-meshheading:1580327-...lld:pubmed
pubmed-article:1580327pubmed:meshHeadingpubmed-meshheading:1580327-...lld:pubmed
pubmed-article:1580327pubmed:meshHeadingpubmed-meshheading:1580327-...lld:pubmed
pubmed-article:1580327pubmed:year1992lld:pubmed
pubmed-article:1580327pubmed:articleTitleA histologic study of the extracellular matrix during the development of glomerulosclerosis in murine chronic graft-versus-host disease.lld:pubmed
pubmed-article:1580327pubmed:affiliationDepartment of Pathology, University of Leiden, The Netherlands.lld:pubmed
pubmed-article:1580327pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1580327pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1580327lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1580327lld:pubmed